Kiniksa Pharmaceuticals
KNSA
#4646
Rank
A$2.44 B
Marketcap
๐Ÿ‡ง๐Ÿ‡ฒ
Country
$33.68
Share price
-6.43%
Change (1 day)
22.84%
Change (1 year)

Kiniksa Pharmaceuticals (KNSA) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : A$0.23 Billion

According to Kiniksa Pharmaceuticals 's latest financial reports the company's total liabilities are A$0.23 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Kiniksa Pharmaceuticals - Total liabilities on balance sheet (from 2017 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$0.22 B77.94%
2023-12-31A$0.12 B37.56%
2022-12-31A$93.34 M41.69%
2021-12-31A$65.88 M34.98%
2020-12-31A$48.8 M17.38%
2019-12-31A$41.57 M-31.4%
2018-12-31A$60.6 M-65.51%
2017-12-31A$0.17 B54.11%
2016-12-31A$0.11 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$51.3 M-78.17%๐Ÿ‡บ๐Ÿ‡ธ USA